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Notice to Healthcare Providers and Public Health Officials: 
Updated Guidance for the Evaluation of Severe Respiratory 
Illness Associated with Middle East Respiratory Syndrome 
Coronavirus (MERS-CoV)
Summary
The Centers for Disease Control and Prevention (CDC) continues to work closely with the World Health 
Organization (WHO) and other partners to better understand the public health risks posed by Middle East 
Respiratory Syndrome Coronavirus (MERS-CoV). To date, no cases have been reported in the United 
States. The purpose o f this health update is 1) to provide updated guidance to healthcare providers and 
state and local health departments regarding who should be tested for MERS-CoV infection, 2) to make 
them aware o f changes to CDC’s “probable case” definition, and 3) to clarify what specimens should be 
obtained when testing for MERS-CoV. Please disseminate this information to infectious disease 
specialists, intensive care physicians, primary care physicians, and infection preventionists, as well as to 
emergency departments and microbiology laboratories.
Background
MERS-CoV, formerly called novel coronavirus, is a beta coronavirus that was first described in 
September 2012. As of August 12, 2013, 94 laboratory-confirmed cases have been reported to WHO. Of 
those cases, 49% (46) were fatal. All diagnosed cases were among people who resided in or traveled 
from four countries (Kingdom of Saudi Arabia, United Arab Emirates, Qatar, or Jordan) within 14 days of 
their symptom onset, or who had close contact with people who resided in or traveled from those 
countries. Cases with a history of travel from these countries or contact with travelers from these 
countries have been identified in residents of France, the United Kingdom, Tunisia, and Italy. To date, no 
cases have been reported in the United States. The most up-to-date details about the number of 
MERS-CoV cases and deaths by country of residence are on CDC’s MERS website 
(http://www.cdc.gov/coronavi rus/m ers/index.html) .
Updates to Interim Guidance and Case Definitions 
Interim Guidance for Health Professionals: Patients in the U.S. Who Should Be Evaluated
CDC has changed its criteria for who should be evaluated for MERS-CoV. In the previous guidance 
(HAN 348, dated June 7, 2013), CDC did not recommend MERS-CoV testing for people whose illness 
could be explained by another etiology. The new guidance states that, in patients who meet certain 
clinical and epidemiologic criteria, testing for MERS-CoV and other respiratory pathogens can be done 
simultaneously and that positive results for another respiratory pathogen should not necessarily preclude 
testing for MERS-CoV.
The new guidance also clarifies recommendations for investigating clusters of severe acute respiratory 
illness when there is not an apparent link to a MERS-CoV case. Clusters* of patients with severe acute
respiratory illness (e.g., fever and pneumonia requiring hospitalization) should be evaluated for common 
respiratory pathogens and reported to local and state health departments. If the illnesses remain 
unexplained, testing for MERS-CoV should be considered, in consultation with state and local health 
departments.
For CDC’s updated interim guidance for healthcare professionals, see 
(http://www.cdc.gov/coronavi rus/m ers/interim-guidance.html) .
Case Definitions
CDC has not changed the case definition of a confirmed case, but the criteria for laboratory confirmation 
have been clarified. CDC has changed its definition of a probable case so that identification of another 
etiology does not exclude someone from being classified as a “probable case.”
For CDC’s updated case definitions, see (http://www.cdc.gov/coronavirus/mers/case-def.html) .
CDC may change its guidance about who should be evaluated and considered a case as we learn more 
about the epidemiology of MERS-CoV infection and risk of transmission.
Interim Guidance about Testing of Clinical Specimens
CDC recommends collecting multiple specimens from different sites at different times after symptom 
onset. Lower respiratory specimens are preferred, but collecting nasopharyngeal and oropharyngeal 
(NP/OP) specimens, as well as stool and serum, are strongly recommended. This will increase the 
likelihood of detecting MERS-CoV infection. For more information, see CDC’s Interim Guidelines for 
Collecting, Handling, and Testing Clinical Specimens (http://www.cdc.gov/coronavirus/mers/guidelines- 
clinical-specimens.html) . Many state health department laboratories are approved for MERS-CoV testing 
using the CDC rRT-PCR assay. Contact your state health department to notify them of people who 
should be evaluated for MERS-CoV and to request MERS-CoV testing. If your state health department is 
not able to test, contact CDC’s EOC at 770-488-7100.
*In accordance with the W HO’s guidance for MERS-CoV, a cluster is defined as two or more persons with 
onset of symptoms within the same 14-day period, and who are associated with a specific setting such as 
a classroom, workplace, household, extended family, hospital, other residential institution, military 
barracks, or recreational camp. See W HO’s Interim Surveillance Recommendations for Human Infection 
with Middle East Respiratory Syndrome Coronavirus
(http://www.who.int/csr/disease/coronavirus infections/InterimRevisedSurveillanceRecommendations nC 
oVinfection 27Jun13.pdf) .
The Centers fo r  Disease Control and Prevention (CDC) protects people’s health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national, and international
organizations.
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